Expression of programmed cell death protein 4 (PDCD4) and miR-21 in urothelial carcinoma

Biochemical and Biophysical Research Communications

Volumn 417, Issue 1, 2012, Pages 29-34

  Fischer, Nicolas ^a   Göke, Friederike ^a   Splittstößer, Vera ^a   Lankat Buttgereit, Brigitte ^b   Müller, Stefan C ^a   Ellinger, Jörg ^a  

^a UNIVERSITY OF BONN   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Bladder; MiR 21; PDCD4; Transitional cell carcinoma; Urologic tumors; Urothelial carcinoma

Indexed keywords

MEMBRANE RECEPTOR; MICRORNA 21; PROGRAMMED CELL DEATH PROTEIN 4; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; DOWN REGULATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR UPREGULATION; RNA ISOLATION; SENSITIVITY AND SPECIFICITY; SMOKING; TRANSITIONAL CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

AGED; AGED, 80 AND OVER; APOPTOSIS REGULATORY PROTEINS; CARCINOMA, TRANSITIONAL CELL; FEMALE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RNA-BINDING PROTEINS; UROLOGIC NEOPLASMS; UROTHELIUM;

EID: 84855765018     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.11.035     Document Type: Article

References (21)

1. Yang H.S., Jansen A.P., Komar A.A., Zheng X., Merrick W.C., Costes S., Lockett S.J., Sonenberg N., Colburn N.H. The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation. Mol. Cell. Biol. 2003, 23:26-37.
2. Yang H.S., Jansen A.P., Nair R., Shibahara K., Verma A.K., Cmarik J.L., Colburn N.H. A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-kappaB or ODC transactivation. Oncogene 2001, 20:669-676.
3. Asangani I.A., Rasheed S.A., Nikolova D.A., Leupold J.H., Colburn N.H., Post S., Allgayer H. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 2008, 27:2128-2136.
4. Lankat-Buttgereit B., Gregel C., Knolle A., Hasilik A., Arnold R., Goke R. Pdcd4 inhibits growth of tumor cells by suppression of carbonic anhydrase type II. Mol. Cell. Endocrinol. 2004, 214:149-153.
5. Leupold J.H., Yang H.S., Colburn N.H., Asangani I., Post S., Allgayer H. Tumor suppressor Pdcd4 inhibits invasion/intravasation and regulates urokinase receptor (u-PAR) gene expression via Sp-transcription factors. Oncogene 2007, 26:4550-4562.
6. Nieves-Alicea R., Colburn N.H., Simeone A.M., Tari A.M. Programmed cell death 4 inhibits breast cancer cell invasion by increasing tissue inhibitor of metalloproteinases-2 expression. Breast Cancer Res. Treat. 2009, 114:203-209.
7. A.C. Schneider, L.C. Heukamp, S. Rogenhofer, G. Fechner, P.J. Bastian, A. von Ruecker, S.C. Muller, J. Ellinger, Global histone H4K20 trimethylation predicts cancer-specific survival in patients with muscle-invasive bladder cancer. BJU. Int. (2011) doi: 10.1111/j.1464-410X.2011.10203.x.
8. Mudduluru G., Medved F., Grobholz R., Jost C., Gruber A., Leupold J.H., Post S., Jansen A., Colburn N.H., Allgayer H. Loss of programmed cell death 4 expression marks adenoma-carcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an independent prognostic factor in resected colorectal cancer. Cancer 2007, 110:1697-1707.
9. Peltier H.J., Latham G.J. Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues. RNA 2008, 14:844-852.
10. Denzinger S., Fritsche H.M., Otto W., Blana A., Wieland W.F., Burger M. Early versus deferred cystectomy for initial high-risk pT1G3 urothelial carcinoma of the bladder: do risk factors define feasibility of bladder-sparing approach?. Eur. Urol. 2008, 53:146-152.
11. Jansen A.P., Camalier C.E., Stark C., Colburn N.H. Characterization of programmed cell death 4 in multiple human cancers reveals a novel enhancer of drug sensitivity. Mol. Cancer Ther. 2004, 3:103-110.
12. Chen Y., Knosel T., Kristiansen G., Pietas A., Garber M.E., Matsuhashi S., Ozaki I., Petersen I. Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis. J. Pathol. 2003, 200:640-646.
13. Zhang H., Ozaki I., Mizuta T., Hamajima H., Yasutake T., Eguchi Y., Ideguchi H., Yamamoto K., Matsuhash S. Involvement of programmed cell death 4 in transforming growth factor-beta1-induced apoptosis in human hepatocellular carcinoma. Oncogene 2006, 25:6101-6112.
14. Wen Y.H., Shi X., Chiriboga L., Matsahashi S., Yee H., Afonja O. Alterations in the expression of PDCD4 in ductal carcinoma of the breast. Oncol. Rep. 2007, 18:1387-1393.
15. Carinci F., Lo Muzio L., Piattelli A., Rubini C., Chiesa F., Ionna F., Palmieri A., Maiorano E., Pastore A., Laino C., et al. Potential markers of tongue tumor progression selected by cDNA microarray. Int. J. Immunopathol. Pharmacol. 2005, 18:513-524.
16. Gao F., Zhang P., Zhou C., Li J., Wang Q., Zhu F., Ma C., Sun W., Zhang W.L. Frequent loss of PDCD4 expression in human glioma: possible role in the tumorigenesis of glioma. Oncol. Rep. 2007, 17:123-128.
17. Wang Q., Sun Z., Yang H.S. Downregulation of tumor suppressor Pdcd4 promotes invasion and activates both beta-catenin/Tcf and AP-1-dependent transcription in colon carcinoma cells. Oncogene 2008, 27:1527-1535.
18. Goke R., Barth P., Schmidt A., Samans B., Lankat-Buttgereit B. Programmed cell death protein 4 suppresses CDK1/cdc2 via induction of p21(Waf1/Cip1). Am. J. Physiol. Cell. Physiol. 2004, 287:C1541-1546.
19. H. Jin, T.H. Kim, S.K. Hwang, S.H. Chang, H.W. Kim, H.K. Anderson, H.W. Lee, K.H. Lee, N.H. Colburn, H.S. Yang, et al., Aerosol delivery of urocanic acid-modified chitosan/programmed cell death 4 complex regulated apoptosis, cell cycle, and angiogenesis in lungs of K-ras null mice. Mol. Cancer Ther. 5 (2006) 1041-1049.
20. Wei N.A., Liu S.S., Leung T.H., Tam K.F., Liao X.Y., Cheung A.N., Chan K.K., Ngan H.Y. Loss of Programmed cell death 4 (Pdcd4) associates with the progression of ovarian cancer. Mol. Cancer. 2009, 8:70.
21. Gaur A.B., Holbeck S.L., Colburn N.H., Israel M.A. Downregulation of Pdcd4 by mir-21 facilitates glioblastoma proliferation in vivo. Neuro. Oncol. 2011, 13:580-590.